SILEXION THERAPEUTICS CORP

Watch

Share

SLXN·G1281K148·US·Common Stock

SLXN (SILEXION THERAPEUTICS CORP) is held by 0 institutional investors as of Q2 2026. Largest holders: HRT FINANCIAL LP ($38,000), UBS Group AG ($3,598), ROYAL BANK OF CANADA ($0). Net institutional sentiment: Bearish.

0

Holders

$0

Total Value

0% (3)

Consensus

0 buying - 3 selling

13F: Jun 30, 2026Insider & Congress: Updated regularly

Smart Money Verdict

View all

Loading verdict

Institutional (13F)56

Insider (Form 4)44

Activist (13D/13G)75

Congressional (STOCK Act)62

Held by 0 funds

Who's Trading

Source dates: Price Oct 12, 2026 · Insiders Jun 8, 2026 · Activists none · Congress none

InsiderSMShirvan MitchellVest 6K shJun 4, 2026

InsiderHIHadar IlanVest 10K shJun 4, 2026

InsiderHMHorenshtein Hadar MiritVest 8K shJun 4, 2026

Checking access…

View all insider trades

Top Holders

Top Holders (0)History

AllNewIncreasedHeldDecreasedExitedFirst report

Checking access…

Fund	Action	Shares	Value	Weight	Est. P&L	Conviction
HRT FINANCIAL LP	New	15,239	$38,000	0.0%	-93.01%	28
UBS Group AG	New	1,411	$3,598	0.0%	-93.01%	21
JONES FINANCIAL COMPANIES LLLP	Exited	0(-100.0%)	$32	0.0%	+47.40%	0
CITADEL ADVISORS LLC	Exited	0(-100.0%)	$26,785	0.0%	+49.93%	0
ROYAL BANK OF CANADA	New	76	$0	0.0%	-93.01%	17

SLXNSILEXION THERAPEUTICS CORP

1M3M6M1Y3Y5Y

Continue exploring

Smart money flow

Track where institutional capital is flowing

Discover new institutional entries

Fresh positions initiated this quarter

Check sector trends

Capital flows across GICS sectors

High Conviction Moves-Smart Money Convergence-Fund Consensus-Double-Down Detection

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer